drugset / Trial / NCT00329108
Ziprasidone And Olanzapine's Outcomes In Mania
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy and tolerability of ziprasidone versus olanzapine in the treatment of acute mania. An open label extension will further evaluate the efficacy, safety, and tolerability of ziprasidone compared with olanzapine. Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on July 30, 2007. Subjects that were enrolled at the time completed the study as per protocol. There were no safety concerns involved in the decision to stop enrollment. The Last Subject Last Visit was January 10, 2008.
Timeline
- Start
- 2006-11
- Primary completion
- 2007-07
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Olanzapine | Small molecule | 15 mg | — |
| Comparator | Olanzapine | Small molecule | 20 mg | — |
| Subject | Ziprasidone | Small molecule | 120 mg | — |
| Subject | Ziprasidone | Small molecule | 160 mg | — |